[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:intrahepatic-cholangiocarcinoma":3},{"name":4,"total":5,"recruiting":6,"trials":7,"biomarkers":162,"states":163},"Intrahepatic Cholangiocarcinoma",25,23,[8,16,23,29,35,41,47,53,60,66,72,78,84,91,97,103,109,115,121,126,132,137,143,149,156],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT06050252","Testing the Combination of the Anticancer Drug Durvalumab With Chemotherapy (Gemcitabine and Cisplatin) at Improving Outcomes for High-Risk Resectable Liver Cancer Before Surgery",[12],"Phase 2","RECRUITING","2026-08-26T02:16:33.772093Z","2026-07-05T05:32:16.740055Z",{"nct_id":17,"title":18,"phases":19,"status":13,"updated_at":21,"content_modified":22},"NCT06058663","Radioembolization With Tremelimumab and Durvalumab for Locally Advanced Unresectable or Oligo-Metastatic Intrahepatic Cholangiocarcinoma",[20],"Phase 1","2026-08-26T02:15:18.897219Z","2026-05-05T02:43:29.511843Z",{"nct_id":24,"title":25,"phases":26,"status":13,"updated_at":27,"content_modified":28},"NCT04078230","Regional or Extend LymphAdenectomy During Resection of Intrahepatic Cholangiocarcinoma",[],"2026-08-26T02:17:23.750999Z","2026-05-05T02:43:29.385129Z",{"nct_id":30,"title":31,"phases":32,"status":13,"updated_at":33,"content_modified":34},"NCT05655949","Y-90 With Durvalumab\u002FGem\u002FCis in Intrahepatic Cholangio",[12],"2026-08-26T02:15:36.077529Z","2026-05-05T02:43:29.327321Z",{"nct_id":36,"title":37,"phases":38,"status":13,"updated_at":39,"content_modified":40},"NCT04891289","Gemcitabine and Oxaliplatin Chemotherapy With or Without a Floxuridine and Dexamethasone Pump in People With Cholangiocarcinoma That Cannot Be Removed With Surgery",[12],"2026-08-26T02:17:48.768272Z","2026-05-05T02:43:29.163198Z",{"nct_id":42,"title":43,"phases":44,"status":13,"updated_at":45,"content_modified":46},"NCT07201519","Study of Safety\u002FFeasibility of a Hybrid Model of Tertiary and Community Delivery of Hepatic Artery Infusion Chemotherapy",[12],"2026-08-26T02:17:28.381459Z","2026-05-05T02:43:28.965510Z",{"nct_id":48,"title":49,"phases":50,"status":13,"updated_at":51,"content_modified":52},"NCT05422690","The Purpose of This Research Study is to See if Combining Gemcitabine, Cisplatin and Durvalumab Chemotherapy Treatments With a Direct Tumor Therapy Yittrium-90 (Y-90) Will Work Better Together to Shrink Tumors and Control Cancer",[12],"2026-08-26T02:15:20.225313Z","2026-05-05T02:43:28.825082Z",{"nct_id":54,"title":55,"phases":56,"status":13,"updated_at":58,"content_modified":59},"NCT03942328","Modified Immune Cells (Autologous Dendritic Cells) and a Vaccine (Prevnar) Combined With Immune Checkpoint Inhibition After High-Dose External Beam Radiation Therapy in Treating Patients With Unresectable Liver Cancer",[57],"Phase 1\u002FPhase 2","2026-08-26T02:18:17.007929Z","2026-05-05T02:43:28.654499Z",{"nct_id":61,"title":62,"phases":63,"status":13,"updated_at":64,"content_modified":65},"NCT05967182","A Single-Arm Study of Pembrolizumab With Gemcitabine and Cisplatin as Perioperative Therapy for Potentially Resectable Intrahepatic Cholangiocarcinoma",[12],"2026-08-26T02:18:24.494016Z","2026-05-05T02:43:28.207276Z",{"nct_id":67,"title":68,"phases":69,"status":13,"updated_at":70,"content_modified":71},"NCT05223816","An Open-Label, Multiple-Center, Phase IIa\u002FIIb Clinical Trial to Evaluate the Efficacy, Safety and Tolerability of VG161 as Monotherapy and in Combination With Nivolumab for Treatment of Patients With Hepatocellular Carcinoma or Intrahepatic Cholangiocarcinoma",[12],"2026-08-26T02:16:31.714843Z","2026-05-05T02:43:28.162660Z",{"nct_id":73,"title":74,"phases":75,"status":13,"updated_at":76,"content_modified":77},"NCT06728410","A Phase II Study of Pemigatinib Plus Durvalumab in Previously Treated Advanced Intrahepatic Cholangiocarcinoma Patients With FGFR-2 Fusion or Rearrangement",[12],"2026-08-26T02:19:05.360997Z","2026-05-05T02:43:27.100443Z",{"nct_id":79,"title":80,"phases":81,"status":13,"updated_at":82,"content_modified":83},"NCT06858735","HYPERION CCA: a Phase 2 Trial of Systemic Therapy With or Without Liver-directed Radiation Therapy for Patients With Advanced Intrahepatic Cholangiocarcinoma",[12],"2026-08-26T02:18:09.641312Z","2026-05-05T02:43:26.903701Z",{"nct_id":85,"title":86,"phases":87,"status":13,"updated_at":89,"content_modified":90},"NCT07265674","A Study to Select a Dose Regimen (Part A) and to Investigate Overall Survival (Part B) With Nanvuranlat Compared With Physician's Best Choice in Participants Aged 18 Years or Older With Biliary Tract Cancer",[88],"Phase 3","2026-08-26T02:19:04.543908Z","2026-05-05T02:43:28.844774Z",{"nct_id":92,"title":93,"phases":94,"status":13,"updated_at":95,"content_modified":96},"NCT07221253","A Study of Rilvegostomig or Durvalumab Plus Chemotherapy for First-Line Treatment of Biliary Tract Cancer (ARTEMIDE-Biliary02)",[88],"2026-08-26T02:17:53.433613Z","2026-05-05T02:43:28.533233Z",{"nct_id":98,"title":99,"phases":100,"status":13,"updated_at":101,"content_modified":102},"NCT07223307","REGULUS: MRI-guided Adaptive SABR for Liver Cancers",[12],"2026-08-26T02:18:22.309547Z","2026-05-05T02:43:27.107508Z",{"nct_id":104,"title":105,"phases":106,"status":13,"updated_at":107,"content_modified":108},"NCT05285358","Pressurized Intraperitoneal Aerosolized Nab-Paclitaxel in Combination With Gemcitabine and Cisplatin for the Treatment of Biliary Tract Cancer Patients With Peritoneal Metastases",[20],"2026-08-26T02:19:13.549512Z","2026-05-05T02:35:31.605465Z",{"nct_id":110,"title":111,"phases":112,"status":13,"updated_at":113,"content_modified":114},"NCT06101277","Locally ablatIVe thErapy for oLigo-progressive gastrOintestiNal maliGnancies (LIVELONG)",[],"2026-08-26T02:16:24.970704Z","2026-07-05T05:32:16.744017Z",{"nct_id":116,"title":117,"phases":118,"status":13,"updated_at":119,"content_modified":120},"NCT07277413","A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors",[20],"2026-08-26T02:16:01.910993Z","2026-07-05T05:32:16.679197Z",{"nct_id":122,"title":123,"phases":124,"status":13,"updated_at":21,"content_modified":125},"NCT07169734","A Study to Investigate ALE.P03 as Monotherapy in Adult Patients With Selected Advanced or Metastatic CLDN1+ Solid Tumors",[57],"2026-05-05T02:43:29.532182Z",{"nct_id":127,"title":128,"phases":129,"status":13,"updated_at":130,"content_modified":131},"NCT02361320","Computed Tomography in Diagnosing Patients With Pancreatic or Hepatobiliary Cancer",[],"2026-08-26T02:17:17.791881Z","2026-04-29T02:57:57.084852Z",{"nct_id":133,"title":134,"phases":135,"status":13,"updated_at":21,"content_modified":136},"NCT06342414","An Exosome-Based Liquid Biopsy for the Differential Diagnosis of Primary Liver Cancer",[],"2026-05-13T02:55:06.444970Z",{"nct_id":138,"title":139,"phases":140,"status":13,"updated_at":141,"content_modified":142},"NCT06140134","Liver Transplantation in Intrahepatic Cholangiocarcinoma",[],"2026-08-26T02:16:13.426928Z","2026-05-13T02:55:06.419152Z",{"nct_id":144,"title":145,"phases":146,"status":13,"updated_at":147,"content_modified":148},"NCT07717437","DRAGON Registry - International Multicenter Registry and Medical Image Bank for Patients With Primarily Unresectable Liver Cancer or Liver Metastases That Underwent Combined Portal and Hepatic Vein Embolization (PVE\u002FHVE) to Increase Future Liver Remnant Before Resection.",[],"2026-08-26T02:19:15.498463Z","2026-07-24T01:27:14.913539Z",{"nct_id":150,"title":151,"phases":152,"status":153,"updated_at":154,"content_modified":155},"NCT07639528","Preoperative Durvalumab, Cisplatin, Gemcitabine With or Without Futibatinib Targeted Therapy for the Treatment of Resectable Intrahepatic Cholangiocarcinoma, OPTIC Trial",[12],"NOT_YET_RECRUITING","2026-08-26T02:18:31.944757Z","2026-06-14T18:39:22.259522Z",{"nct_id":157,"title":158,"phases":159,"status":153,"updated_at":160,"content_modified":161},"NCT07715903","Hepatic Artery Infusion of Carfilzomib in Participants With Liver Metastatic Disease Previously Treated With Hepatic Artery Infusion Pump Therapy",[20],"2026-08-26T02:19:28.327680Z","2026-07-24T01:27:14.914242Z",[],[164,168,172,176,179,182,186,189,192,196,199,203,206,209],{"state":165,"count":166,"slug":167},"California",9,"california",{"state":169,"count":170,"slug":171},"Texas",8,"texas",{"state":173,"count":174,"slug":175},"Florida",6,"florida",{"state":177,"count":174,"slug":178},"Illinois","illinois",{"state":180,"count":174,"slug":181},"New York","new-york",{"state":183,"count":184,"slug":185},"Maryland",5,"maryland",{"state":187,"count":184,"slug":188},"Minnesota","minnesota",{"state":190,"count":184,"slug":191},"New Jersey","new-jersey",{"state":193,"count":194,"slug":195},"Kentucky",4,"kentucky",{"state":197,"count":194,"slug":198},"Virginia","virginia",{"state":200,"count":201,"slug":202},"Arizona",3,"arizona",{"state":204,"count":201,"slug":205},"Connecticut","connecticut",{"state":207,"count":201,"slug":208},"Ohio","ohio",{"state":210,"count":201,"slug":211},"Pennsylvania","pennsylvania"]